Cilostazol trial
Not Applicable
- Conditions
- peripheral arterial disease
- Registration Number
- JPRN-UMIN000001198
- Lead Sponsor
- Kokura Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
previous lower extremity bypass surgery, previous EVT in the femoropopliteal artery, acute onset limb ischemia, or severe lower extremity ischemic symptoms classified into Rutherford Category 4, 5 or 6, known bleeding diathesis, hepatic dysfunction, active gastrointestinal bleeding or peptic ulcer disease, intolerance to cilostazol, aspirin or ticlopidine, pregnant women and women of child-bearing potential, and major life-threatening illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method target vessel revascularization
- Secondary Outcome Measures
Name Time Method major adverse cardiovascular event, restenosis rate